(Q50998040)

26 March 2018

title

Efficacy of sotrastaurin plus tacrolimus after de novo kidney transplantation: randomized, phase II trial results. (English)

1 reference

26 March 2018

main subject

phase II clinical trial

0 references

author name string

G R Russ

1

1 reference

26 March 2018

H Tedesco-Silva

2

1 reference

26 March 2018

D R Kuypers

3

1 reference

26 March 2018

S Cohney

4

1 reference

26 March 2018

R M Langer

5

1 reference

26 March 2018

O Witzke

6

1 reference

26 March 2018

J Eris

7

1 reference

26 March 2018

C Sommerer

8

1 reference

26 March 2018

B von Zur-Mühlen

9

1 reference

26 March 2018

E S Woodle

10

1 reference

26 March 2018

J Gill

11

1 reference

26 March 2018

J Ng

12

1 reference

26 March 2018

J Klupp

13

1 reference

26 March 2018

L Chodoff

14

1 reference

26 March 2018

K Budde

15

1 reference

26 March 2018

language of work or name

English

0 references

publication date

13 May 2013

1 reference

26 March 2018

American Journal of Transplantation

published in

1 reference

26 March 2018

volume

13

1 reference

26 March 2018

issue

7

1 reference

26 March 2018

page(s)

1746-1756

1 reference

26 March 2018

Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus

cites work

1 reference

Immunosuppression: evolution in practice and trends, 1994-2004.

21 January 2018

1 reference

Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus

21 January 2018

1 reference

Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies

21 January 2018

1 reference

Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management

21 January 2018

1 reference

Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients.

21 January 2018

1 reference

The potent protein kinase C-selective inhibitor AEB071 (sotrastaurin) represents a new class of immunosuppressive agents affecting early T-cell activation.

21 January 2018

1 reference

Evaluation of the novel protein kinase C inhibitor sotrastaurin as immunosuppressive therapy after renal transplantation.

21 January 2018

1 reference

Sotrastaurin, a novel small molecule inhibiting protein kinase C: first clinical results in renal-transplant recipients.

21 January 2018

1 reference

Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients.

21 January 2018

1 reference

Banff 07 classification of renal allograft pathology: updates and future directions

21 January 2018

1 reference

Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

Estimates of Location Based on Rank Tests

21 January 2018

1 reference

Relationship of tacrolimus exposure and mycophenolate mofetil dose with renal function after renal transplantation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/AJT.12251

1 reference

26 March 2018

PubMed ID

23668931

1 reference

26 March 2018